Ling‐Ling Chen
- Cancer Research top 0.01%
- Cancer-related molecular mechanisms research 56
- MicroRNA in disease regulation 31
- Molecular Biology top 0.05%
- RNA Research and Splicing 69
- RNA modifications and cancer 58
- Circular RNAs in diseases 43
- RNA and protein synthesis mechanisms 19
- RNA regulation and disease 15
- Endocrinology top 1%
- Immunology top 2%
- Aging top 5%
-
- Peptidase Inhibition and Analysis 11
- Co-authors
- Li YangChunjie GuoMaite HuarteLuisa StatelloGordon CarmichaelXiao‐Ou ZhangYang ZhangRun-Wen Yao
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Ling‐Ling Chen
200 papers receiving 27.6k citations
Hit Papers
Peers
Comparison fields: 5 of 174
- Cancer Research 19.3k
- Molecular Biology 24.9k
- Endocrinology 427
- Immunology 1.3k
- Aging 50
Countries citing papers authored by Ling‐Ling Chen
This map shows the geographic impact of Ling‐Ling Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling‐Ling Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling‐Ling Chen more than expected).
Fields of papers citing papers by Ling‐Ling Chen
This network shows the impact of papers produced by Ling‐Ling Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling‐Ling Chen. The network helps show where Ling‐Ling Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ling‐Ling Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 3 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 2 | |
| 10 | 2020 | 247 | |
| 11 | 2019 | 1 | |
| 12 | 2019 | 6 | |
| 13 | 2018 | 0 | |
| 14 | 2017 | 7 | |
| 15 | Diverse alternative back-splicing and alternative splicing landscape of circular RNAsbreakdown → | 2016 | 754 |
| 16 | Antidepressant-like effect of DS-1226 on chronic restraint rats | 2013 | 2 |
| 17 | 2010 | 51 | |
| 18 | 2005 | 15 | |
| 19 | 2005 | 16 | |
| 20 | 2004 | 22 |
About Ling‐Ling Chen
Ling‐Ling Chen is a scholar working on Cancer Research, Molecular Biology, Immunology, Oncology and Endocrinology, having authored 210 papers that have together received 27.8k indexed citations. Recurring topics across this work include RNA Research and Splicing (69 papers), RNA modifications and cancer (58 papers), Cancer-related molecular mechanisms research (56 papers), Circular RNAs in diseases (43 papers), MicroRNA in disease regulation (31 papers), RNA and protein synthesis mechanisms (19 papers), RNA regulation and disease (15 papers) and Peptidase Inhibition and Analysis (11 papers). The work is most often cited by research in Cancer Research (19.3k citations), Molecular Biology (24.9k citations), Endocrinology (427 citations), Immunology (1.3k citations) and Aging (50 citations). Ling‐Ling Chen has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Li Yang, Chunjie Guo, Maite Huarte, Luisa Statello, Gordon Carmichael, Xiao‐Ou Zhang, Yang Zhang, Run-Wen Yao, Xiang Li and Chu‐Xiao Liu. Their work appears in journals such as Molecular Cell, Cell, Genome biology, Cell Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.